COMP <GO>
QGEN vs TWST // EV/EBITDA & P/E VALUATION
Qiagen N.V. (NYSE) VS. Twist Bioscience Corporation (NASDAQ) • 15-METRIC TALLY: QGEN 7
— TWST 6
■ METRIC PARITY
LAST: $50.22 (-0.24%) • MKT CAP: $10.37B
valuation
17.6x
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QGEN VS. TWST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QGEN | TWST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.20% | 94.20% | -32.00 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | -11.70% | +19.70 | QGEN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.37% | -0.66% | +5.03 | QGEN | /fcf-yield <GO> |
| Operating Margin | 22.30% | -4.20% | +26.50 | QGEN | /operating-margins <GO> |
| Net Profit Margin | 20.30% | -2.40% | +22.70 | QGEN | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 16.50% | -10.80 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 0.00% | +0.52 | QGEN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.54 | 26.00 | -22.46 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | QGEN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.4 | 57.2 | +15.20 | QGEN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.98 | -0.03 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.7x | 21.0x | +1.70 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.37B | $11.50B | -$1.13B | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QGEN REV | TWST REV | QGEN GROSS % | TWST GROSS % | QGEN FCF | TWST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | $0 | 62.2% | — | $453.3M | -$75.6M |
| FY 2024 | $1.98B | $0 | 48.9% | — | $506.4M | -$69.2M |
| FY 2023 | $1.97B | $0 | — | — | $371.0M | -$142.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QGEN // BETA 0.95
TWST // BETA 0.98